Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2026-01-02 00:00:00 ET · period of report 2026-01-01 · accession 0001922964-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-02 | 2026-01-01 | MYGN | Muzzey Dale | CSO | F - Tax | $6.15 | -418 | 170.2K | -0.2% | -$2,571 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-01 | F | D | 418 | $6.15 | 170,181 | D | — | — | (F1) Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on December 31, 2025. |